Yahoo Web Search

Search results

1. • BrainsWay (BWAY) Inks Distribution Agreement to Expand Foothold

     Zacks· 1 day ago

     Free Report) recently signed an exclusive multi-year distribution agreement with a specialty distributor serving both the acute hospital and non-acute healthcare spaces in Canada. The deal will ...

2. • Avinger Announces Closing of up to $24 Million Public Offering

     Digital Journal· 3 days ago

     ...are not limited to, market and other conditions, our ability to manage our company with fewer employees, dependency on a limited number of products; the resource requirements related to Pantheris, Tigereye and our Lightbox imaging console; the outcome of clinical trial results; the adoption of...

3. • 

     U.S. Expands Russia Sanctions, Focusing on Financial Infrastructure and IT/Software-Related Services

     The National Law Review· 6 days ago

     The new sanctions target individuals and entities whose products and services “enable Russia to...

4. • 

     Innovent Delivers Oral Presentation on Clinical Data of IBI363 (First-in-class PD-1/IL-2α-bias...

     FOX40 Sacramento· 7 days ago

     ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and...

5. • HUTCHMED Highlights Publication of Phase III ESLIM-01 Results in The Lancet Haematology - HUTCHMED...

     Benzinga· 4 days ago

     — Publication shows treatment demonstrated durable response rate of 48.4% vs. 0% with placebo — — Presentations at EHA showcased subgroup analyses demonstrating consistent benefits regardless of prior lines of

6. • 

     Exploring Growth Potential: 3 Euronext Paris Stocks With At Least 10% Insider Ownership

     Simply Wall St. via Yahoo Finance· 1 day ago

     Amidst a backdrop of political uncertainty and fluctuating market conditions in Europe, particularly...

7. • Avinger Announces Pricing of up to $24 Million Public Offering

     Digital Journal· 6 days ago

     ...are not limited to, market and other conditions, our ability to manage our company with fewer employees, dependency on a limited number of products; the resource requirements related to Pantheris, Tigereye and our Lightbox imaging console; the outcome of clinical trial results; the adoption of...

8. • 

     Late-breaking results show nipocalimab significantly improves Sjögren's disease activity in a Phase...

     FOX 23 News Albany· 5 days ago

     Johnson & Johnson (NYSE: JNJ) announces patients treated with nipocalimab demonstrated statistically...

9. • 

     Drug names: How companies and regulators come up with hundreds of new names every year

     Quartz· 21 hours ago

     Everything you need to know about the art and science of drug naming in five minutes or less,...

10. • Alzheimer’s Awareness Month is Now | Newswise

      Newswise· 1 day ago

      June is Alzheimer’s & Brain Awareness Month. Increased public awareness and understanding are essential as the number of people diagnosed with Alzheimer’s continues to rise. The Alzheimer’s ...